Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Cancer-Causing Agent in Cigarette Smoke Blocks Key Protein in Cells

By BiotechDaily International staff writers
Posted on 17 Apr 2012
Researchers have uncovered new evidence of a cancer-causing agent present in the gaseous phase of cigarette smoke that inhibits Na,K-ATPase, the sodium-potassium pump essential for the healthy, physiological functioning of cells.

Cigarette smoke (CS) has more than 4,000 components, many of which are linked to the development and progression of lung cancer. Evidence has shown secondhand smoke to be almost as dangerous as primary smoke due to its impact on the cells of the body.

By studying lung cell cultures exposed to CS, the investigators identified a cancer-causing agent called reactive oxygen species (ROS) present in the gaseous phase of CS that disrupts normal cell function. Exposure to the secondhand smoke produced by as little as two cigarettes was found to almost completely inhibit Na,K-ATPase activity within a few hours.

They further examined whether Na,K-ATPase expression correlated with increasing grades of lung adenocarcinoma and survival of patients with smoking history. Immunohistochemical analysis of lung adenocarcinoma tissues revealed reduced Na,K-ATPase expression with increasing tumor grade. Using tissue microarray containing lung adenocarcinomas of patients with known smoking status, high expression of Na,K-ATPase was found to be correlated with better survival.

Overall, reduced competence of the cell's ability to regulate sodium-potassium levels was predictive of cell damage, disease progression and, ultimately, survival. For the first time, CS is shown to be associated with loss of Na,K-ATPase function and expression in lung carcinogenesis, and likely also contributes to disease progression.

"This is critical information with regard to secondhand smoke. [...] Exposure to the gaseous substance alone, which you breathe while standing near a smoker, is sufficient to cause harm," said A. K. Rajasekaran, PhD, lead scientist of the study and Director of the Nemours Center for Childhood Cancer Research (Nemours; Wilmington, DE, USA).

Dr. Lee Goodglick, Associate Professor in the Department of Pathology and Laboratory Medicine, University of California at Los Angeles (UCLA; Los Angeles, CA, USA) and cosenior author of the study, noted, "Few reliable lung cancer biomarkers that could predict survival, treatment options or response to therapy exist today. Even fewer have been recognized where the function of the biomarker is known, yielding important information about the mechanism of action. This study really accomplishes both."

This research, reported online ahead of print February 17, 2012, in the American Journal of Physiology - Lung Cell and Molecular Physiology,is the latest finding in the compendium of evidence that supports protection, especially for children, from exposure to cigarette smoke, and reveals that secondhand smoke may be even more dangerous than previously thought.

Related Links:
Nemours Center for Childhood Cancer Research
University of California at Los Angeles



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A scheme for the generation of induced pluripotent stem cells (IPSC). (1) Isolate and culture donor cells. (2) Transfect stem cell-associated genes into the cells by viral vectors. Red cells indicate the cells expressing the exogenous genes. (3)  Harvest and culture the cells using mitotically inactivated feeder cells. (4) A small subset of the transfected cells forms iPSC cell colonies (Photo courtesy of Wikimedia Commons).

Innovative Technique Produces More Reliable Pluripotent Stem Cells

A recent paper described a more reliable way to induce the formation of pluripotent stem cells (iPSCs) from adult cells in a mouse model. Reliable high-quality iPSCs are needed for the development of... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.